{"id":30303,"date":"2024-10-04T07:00:00","date_gmt":"2024-10-04T07:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4521720_AE21720_0"},"modified":"2024-10-04T07:00:00","modified_gmt":"2024-10-04T07:00:00","slug":"clarivate-in-partnership-with-abiquifi-announces-annual-summit-latam-agenda","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=30303","title":{"rendered":"Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda"},"content":{"rendered":"\n\n\n
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities in Latin America<\/span> at premier Life Sciences event<\/p>\n

LONDON<\/span>, Oct. 4, 2024<\/span> \/PRNewswire\/ — Clarivate Plc<\/a> (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 2nd<\/sup> annual Summit LATAM<\/a>, which will be held in Milan<\/span> on October 7, 2024<\/span>, ahead of the CPHI Milan conference.<\/a> In partnership with the Brazilian Association of the Pharmaceutical Ingredients Industry<\/a> (Abiquifi), this year’s event reinforces the industry’s commitment to patient welfare by showcasing how collective efforts and innovative strategies are reshaping the pharmaceutical ecosystem, with a focus on navigating market challenges and uncovering innovation opportunities.<\/p>\n

In the wake of the pandemic, the global pharmaceutical industry faced a slowdown in growth, prompting companies to swiftly identify new opportunities and areas of innovation. As the Latin American market is valued at $98 billion<\/span>,1<\/sup> with projected growth of 10.1%\u2014outpacing North America<\/span> (3.1%) and Europe<\/span> (3.9%)\u2014navigating this region is crucial for the future of the global pharmaceutical landscape. To maintain a competitive edge and ensure return on investment, organizations must adopt effective, cross-functional solutions. Summit LATAM 2024 will offer attendees the chance to explore obstacles, discover new opportunities, and discuss strategies for accelerating development processes in the region.<\/p>\n

Henry Levy<\/span>, President, Life Sciences and Healthcare, Clarivate, said<\/b>: “At Clarivate, we have been committed to driving innovation and delivering strategic solutions in Latin America<\/span> for over two decades. Our mission is to foster collaboration across the life sciences and healthcare sectors, empowering organizations to navigate the evolving pharmaceutical landscape. We are proud to unite industry leaders through Clarivate Summit LATAM, in partnership with ABIQUIFI, to address the region’s most pressing challenges and unlock new opportunities for growth and innovation.” <\/p>\n

Norberto<\/b> Prestes, President, <\/b>Abiquifi, said:<\/b> “There can be no serious and efficient planning if we don’t have quality data. Abiquifi has innovation as a priority part of its strategy and to this end we are expanding our partnership with Clarivate so that we can carry out a quality LATAM mobilization in order to expand the production and development of innovative IFAS in the bloc. The meetings we hold in each country are guided by the data provided by Clarivate. The high-quality information brings the LATAM reality to the center of discussions and helps us define priorities, understand where there are opportunities to act in the medium term and what we should invest in long-term research in the region.” <\/p>\n

Cristian Madoery, Director Sales Latam, Life Sciences and Healthcare, Clarivate, said:<\/b> “Summit LATAM Milan offers a valuable opportunity to connect with key leaders in the Latin American pharmaceutical sector. Clarivate has been actively fostering an ecosystem in Latin America<\/span>, bringing together diverse players to strengthen the region’s immense professional and technological potential. Platforms like this are enriching for all involved, providing a unique chance to share ideas, exchange knowledge, and learn from one another.”<\/p>\n

This year’s agenda features insights and perspectives from industry leaders and analysts, with sessions focused on innovative partnerships, artificial intelligence, regulatory guidelines and API production. Noteworthy sessions include:<\/p>\n